The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring
Abstract
We aimed to estimate the prevalence of resistant hypertension through both office and ambulatory blood pressure monitoring in a large cohort of treated hypertensive patients from the Spanish Ambulatory Blood Pressure Monitoring Registry. In addition, we also compared clinical features of patients with true or white-coat–resistant hypertension. In December 2009, we identified 68 045 treated patients with complete information for this analysis. Among them, 8295 (12.2% of the database) had resistant hypertension (office blood pressure ≥140 and/or 90 mm Hg while being treated with ≥3 antihypertensive drugs, 1 of them being a diuretic). After ambulatory blood pressure monitoring, 62.5% of patients were classified as true resistant hypertensives, the remaining 37.5% having white-coat resistance. The former group was younger, more frequently men, with a longer duration of hypertension and a worse cardiovascular risk profile. The group included larger proportions of smokers, diabetics, target organ damage (including left ventricular hypertrophy, impaired renal function, and microalbuminuria), and documented cardiovascular disease. Moreover, true resistant hypertensives exhibited in a greater proportion a riser pattern (22% versus 18%; P <0.001). In conclusion, this study first reports the prevalence of resistant hypertension in a large cohort of patients in usual daily practice. Resistant hypertension is present in 12% of the treated hypertensive population, but among them more than one third have normal ambulatory blood pressure. A worse risk profile is associated with true resistant hypertension, but this association is weak, thus making it necessary to assess ambulatory blood pressure monitoring for a correct diagnosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among treated adults with hypertension, prevalent aTRH occurs in ≈12% to 15% of population-based13–16 and 15% to 18% of clinic-based reports.17–20”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
Self-citationPickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
Verdecchia, P., Porcellati, C., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Guerrieri, M., Gatteschi, C., Zampi, I., Santucci, A., et al. (1994) · Hypertension · doi:10.1161/01.hyp.24.6.793 · Cited by 1,671
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,416
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Ohkubo, T., Hozawa, A., Yamaguchi, J., Kikuya, M., Ohmori, K., Michimata, M., Matsubara, M., Hashimoto, J., Hoshi, H., Araki, T., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00017 · Cited by 1,053
Cited by
Sorted by citations
Items 201–300 of 808
I posicionamento brasileiro sobre hipertensão arterial resistente
Alessi, A., Brandão, A. A., Coca, A., Cordeiro, A. C., Cordeiro, A., Nogueira, A. D. R., de Magalhães, F. D., Feitosa, A. D. M., Amodeo, C., Rodrigues, C. I. S., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012000700002 · Cited by 29
Capítulo 14 – Crise Hipertensiva
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Figueiredo, C., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160164 · Cited by 32
The Prevalence and Prognosis of Resistant Hypertension in Patients with Heart Failure
Jin, C.-N., Liu, M., Sun, J.-P., Fang, F., Wen, Y.-N., Yu, C.-M., & Lee, A. P.-W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114958 · Cited by 29
Wang, J., Yin, Y., Lu, C., Lu, Z., Hu, J., Wang, Y., Ge, J., Jiang, H., Yao, C., Yan, X., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102626 · Cited by 31
Resistant Hypertension: Concepts and Approach to Management
Sander, G. E., & Giles, T. D. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0226-7 · Cited by 29
de Souza, F., Muxfeldt, E. S., & Salles, G. F. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.58 · Cited by 29
Gijón‐Conde, T., Graciani, A., & Banegas, J. R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.09.027 · Cited by 28
Self-citationSiddiqui, M., Bhatt, H., Judd, E. K., Oparil, S., & Calhoun, D. A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa042 · Cited by 29
White Coat Hypertension: to Treat or Not to Treat?
Cuspidi, C., Sala, C., Grassi, G. M., & Mancia, G. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0687-9 · Cited by 29
Lazaridis, A. A., Sarafidis, P. A., & Ruilope, L. M. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0590-9 · Cited by 29
Self-citationBhatt, H., Safford, M. M., & Glasser, S. P. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0541-5 · Cited by 27
Pathak, A., Ewen, S., Fajadet, J. C., Honton, B., Mahfoud, F., Marco, J., Schlaich, M. P., Schmieder, R. E., Tsioufis, K. P., Ukena, C., et al. (2014) · EuroIntervention · doi:10.4244/eijv10i1a4 · Cited by 29
The Prevalence, Incidence, Prognosis, and Associated Conditions of Resistant Hypertension
Vega, J., & Bisognano, J. D. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.04.002 · Cited by 28
Resistant hypertension: a practical clinical approach
Muxfeldt, E. S., de Souza, F., & Salles, G. F. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.34 · Cited by 29
A nurse‐coordinated model of care versus usual care for chronic kidney disease: meta‐analysis
Xu, H., Mou, L., & Cai, Z. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13533 · Cited by 28
Implementing ABPM into Clinical Practice
Hinderliter, A. L., Voora, R. A., & Viera, A. J. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0805-y · Cited by 29
Resistant Hypertension, Patient Characteristics, and Risk of Stroke
Hung, C.-Y., Wang, K.-Y., Wu, T.-J., Hsieh, Y.-C., Huang, J.-L., Loh, E.-W., & Lin, C.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104362 · Cited by 27
Resistant Hypertension in Nondialysis Chronic Kidney Disease
Borrelli, S., Nicola, L. D., Stanzione, G., Conte, G., & Minutolo, R. (2013) · International Journal of Hypertension · doi:10.1155/2013/929183 · Cited by 27
Narayan, H., & Webb, D. J. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0643-8 · Cited by 27
Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
Yugar‐Toledo, J. C., Moreno, H., Gus, M., Rosito, G. B. A., Scala, L. C. N., Muxfeldt, E. S., Alessi, A., Brandão, A. A., Filho, O. M., Feitosa, A. D. M., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200198 · Cited by 33
Marin, F., Fezzi, S., Gambaro, A., Ederle, F., Castaldi, G., Widmann, M., Gangemi, C., Ferrero, V., Pesarini, G., Pighi, M., et al. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-00966-7 · Cited by 27
When blood pressure refuses to budge: exploring the complexity of resistant hypertension
Champaneria, M. K., Patel, R., & Oroszi, T. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1211199 · Cited by 30
Deep Brain Stimulation for the Treatment of Resistant Hypertension
O'Callaghan, E., McBryde, F. D., Burchell, A., Ratcliffe, L., Nicolae, L., Gillbe, I., Carr, D., Hart, E., Nightingale, A., Patel, N. K., et al. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0493-1 · Cited by 27
White-Coat Effect Is Uncommon in Patients With Refractory Hypertension
Siddiqui, M., Judd, E. K., Oparil, S., & Calhoun, D. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09464 · Cited by 27
Elmula, F. E. M. F., Rebora, P., Talvik, A., Salerno, S., Miszkowska-Nagórna, E., Liu, X., Heinpalu-Kuum, M., Comotti, T., Larstorp, A. C. K., Rostrup, M., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000749 · Cited by 26
Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension
Jansen, P. M., Frenkel, W. J., van den Born, B. H., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Arnoldus, J. H. A., Woittiez, A. J. J., Wijbenga, J. A. M., Zietse, R., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835b71d6 · Cited by 26
Carey, R. M. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00601 · Cited by 28
Ebinger, J. E., Gluckman, T. J., Magraner, J., Chiu, S. T., Rider, D., Thomas, C., Das, S. R., Ho, P. M., Shreenivas, S., & Bradley, S. M. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20894 · Cited by 26
Ott, C., Lobo, M. D., Sobotka, P. A., Mahfoud, F., Stanton, A. V., Cockcroft, J., Sulke, N., Dolan, E., van der Giet, M., Hoyer, J. D., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004234 · Cited by 25
Agarwal, R., Rossignol, P., Garza, D., Mayo, M. R., Warren, S., Arthur, S. P., Romero, A., White, W. B., & Williams, B. (2018) · American Journal of Nephrology · doi:10.1159/000492622 · Cited by 25
Wearable cuffless blood pressure monitoring: From flexible electronics to machine learning
Hua, J., Su, M., Wu, J., Zhou, Y., Guo, Y., Shi, Y., & Pan, L. (2024) · Wearable electronics. · doi:10.1016/j.wees.2024.05.004 · Cited by 29
Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension
Grassi, G. M., Bombelli, M., Seravalle, G., Brambilla, G., Dell’Oro, R., & Mancia, G. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0349-0 · Cited by 23
Clinical situations associated with difficult-to-control hypertension
Oliveras, A., & Schmieder, R. E. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835d2af0 · Cited by 24
Self-citationEstándares SEA 2019 para el control global del riesgo cardiovascular
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Ascaso, J. F., Valdivielso, P., Velilla, T. A., Brea, Á., Calmarza, P., Cebollada, J., et al. (2019) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.03.004 · Cited by 36
Self-citationMallamaci, F., Torino, C., Sarafidis, P. A., Ekart, R., Loutradis, C., Siamopoulos, K. C., Giudice, A. D., Aucella, F., Morosetti, M., Raptis, V., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002448 · Cited by 24
Antihypertensive therapy and short-term blood pressure variability
de la Sierra, A., Mateu, A., Gorostidi, M., Vinyoles, E., Segura, J., & Ruilope, L. M. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002618 · Cited by 25
Self-citationYoon, M., You, S. C., Oh, J., Lee, C. J., Lee, S., Kang, S., & Park, S. (2022) · Hypertension Research · doi:10.1038/s41440-021-00845-5 · Cited by 24
Resistant hypertension: consensus document from the Korean society of hypertension
Park, S., Shin, J., Ihm, S., Kim, K., Kim, H., Kim, H. C., Lee, E. M., Lee, J. H., Ahn, S. Y., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00255-4 · Cited by 26
Prognostic Value of C-Reactive Protein in Resistant Hypertension
Cortez, A. F., Muxfeldt, E. S., Cardoso, C. R. L., & Salles, G. F. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw011 · Cited by 25
Cardoso, C. R. L., Salles, G. C., & Salles, G. F. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14782 · Cited by 24
Apparent and true resistant hypertension: Why not the same?
Calhoun, D. A. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.07.007 · Cited by 24
Resistant Hypertension and Mortality: An Observational Cohort Study
de la Sierra, A., Ruilope, L. M., Staplin, N., Gorostidi, M., Vinyoles, E., Segura, J., Armario, P., Oliveras, A., & Williams, B. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23276 · Cited by 26
Self-citationCalhoun, D. A. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.5.593 · Cited by 23
Evaluating the carotid bodies and renal nerves as therapeutic targets for hypertension
McBryde, F. D., Hart, E. C., Ramchandra, R., & Paton, J. F. R. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.08.002 · Cited by 23
Ambulatory blood pressure in hypertensive patients with inclusion criteria for the SPRINT trial
de la Sierra, A., Banegas, J. R., Divisón, J. A., Gorostidi, M., Vinyoles, E., de la Cruz, J. J., Segura, J., & Ruilope, L. M. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.10.013 · Cited by 23
Self-citationResistant hypertension: new insights and therapeutic perspectives
Ruilope, L. M., Rodríguez‐Sánchez, E., Navarro‐García, J. A., Segura, J., Ortíz, A., Lucía, A., & Ruiz‐Hurtado, G. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz057 · Cited by 24
Self-citationHolmqvist, L. D., Boström, K. B., Kahan, T., Schiöler, L., Hasselström, J., Hjerpe, P., Wettermark, B., & Manhem, K. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.08.008 · Cited by 23
Eikelis, N., Marques, F. Z., Hering, D., Marušić, P., Head, G. A., Walton, A., Lambert, É., Esler, M., Sari, C. I., Schlaich, M. P., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001736 · Cited by 23
Romano, S. L., Idolazzi, C., Fava, C., Fondrieschi, L., Celebrano, M., Delva, P., Branz, L., Donato, A. D., Dalbeni, A., & Minuz, P. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0268-x · Cited by 23
Obstructive sleep apnea syndrome and sleep quality in hypertensive patients
Bacci, M. R., Emboz, J. N. M., Alves, B. D. C. A., da Veiga, G. L., Murad, N., Meneghini, A., Chagas, A. C. P., & Fonseca, F. L. A. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.12.1055 · Cited by 22
Hayes, P., Casey, M., Glynn, L. G., Molloy, G. J., Durand, H., O'Brien, E. T., Dolan, E., Das, K., Newell, J., Finn, D. P., et al. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x705077 · Cited by 22
on behalf of the Spanish Sleep Network, Navarro‐Soriano, C., Martínez‐García, M. Á., Torres, G., Barbé, F., Caballero‐Eraso, C., Lloberes, P., Díaz-Cambriles, T., Somoza, M., Masa, J. F., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0285-8 · Cited by 21
Cardiovascular risk assessment in children following kidney transplantation
Dégi, A. A., Kerti, A., Kis, É., Cseprekál, O., Tory, K., Szabo, A. J., & Reusz, G. (2012) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2012.01730.x · Cited by 22
Abnormalities of vascular function in resistant hypertension
de La Sierra, A., Larrousse, M., Oliveras, A., Armario, P., Hernández-Del Rey, R., Poch, E., & Roca-Cusachs, A. (2012) · Blood Pressure · doi:10.3109/08037051.2011.622983 · Cited by 21
Self-citationTraditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women
Mehta, P. K., Gaignard, S. M., Schwartz, A. M., & Manson, J. E. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308288 · Cited by 23
Massierer, D., Oliveira, A. C. T., Steinhorst, A. M. P., Gus, M., Ascoli, A. M., Gonçalves, S. C., Moreira, L. B., Correa, V., Nunes, G. L. D. S., Fuchs, S. C. P. C., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012005000051 · Cited by 21
Glicklich, D., & Frishman, W. H. (2015) · Drugs · doi:10.1007/s40265-015-0372-3 · Cited by 21
Hein, M., Lanquart, J., Hubain, P., & Loas, G. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.05.013 · Cited by 23
Resistant hypertension-defining the scope of the problem
Chia, R., Pandey, A., & Vongpatanasin, W. (2019) · Progress in cardiovascular diseases · doi:10.1016/j.pcad.2019.12.006 · Cited by 14
Lithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc13-2023 · Cited by 21
Faconti, L., George, J., Partridge, S., Maniero, C., Sathyanarayanan, A., Kulkarni, S., Kapil, V., Petrosino, A., Lewis, P., McCormack, T., et al. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00983-6 · Cited by 23
Schmieder, R. E., Ruilope, L. M., Ott, C., Mahfoud, F., & Böhm, M. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.39 · Cited by 19
Self-citationMundt, H. M., Matenaer, M., Lammert, A., Göttmann, U., Krämer, B. K., Birck, R., & Benck, U. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12847 · Cited by 21
Sun, L., Chang, Y.-F., Wang, Y., Xie, Q.-X., Ran, X.-Z., Hu, C., Luo, B., & Ning, B. (2024) · Current Hypertension Reports · doi:10.1007/s11906-024-01294-4 · Cited by 20
Miroslawska, A., Solbu, M. D., Skjølsvik, E., Toft, I., & Steigen, T. K. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.69 · Cited by 20
Validation of a therapeutic scheme for the treatment of resistant hypertension
Segura, J., Cerezo, C., García‐Donaire, J. A., Schmieder, R. E., Praga, M., de la Sierra, A., & Ruilope, L. M. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.08.003 · Cited by 20
Self-citationExpanding the indication spectrum: renal denervation in diabetes
Mahfoud, F., Ewen, S., Ukena, C., Linz, D., Sobotka, P. A., Cremers, B., & Böhm, M. (2013) · EuroIntervention · doi:10.4244/eijv9sra20 · Cited by 19
Cao, G., Chen, C., Lin, Q., Chen, Y., Zhen, Z., Zou, Y., Liu, J., Wu, M., Wang, R., Liu, M., et al. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1272398 · Cited by 20
Resistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Renal sympathetic nerve ablation for treatment‐resistant hypertension
Krum, H., Schlaich, M. P., & Sobotka, P. A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12171 · Cited by 20
Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
Kaboré, J., Metzger, M., Helmer, C., Berr, C., Tzourio, C., Massy, Z. A., & Stengel, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146056 · Cited by 20
Treatment Resistant Hypertension
Weber, F., & Anlauf, M. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0425 · Cited by 20
Capítulo 9 - Hipertensão Arterial na gestação
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Poli‐de‐Figueiredo, C. E., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160159 · Cited by 22
Resistant hypertension: Diagnosis, evaluation, and treatment practical approach
Parodi, R., Brandani, L., Romero, C. R., & Klein, M. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.12.026 · Cited by 20
Renal denervation for the management of resistant hypertension
Patel, H. C., Hayward, C., Vassiliou, V. S., Patel, K., Howard, J. P., & Mario, C. D. (2015) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s65632 · Cited by 19
Renal Denervation: A Potential New Treatment for Severe Hypertension
Huan, Y., & Cohen, D. L. (2012) · Clinical Cardiology · doi:10.1002/clc.22071 · Cited by 19
Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM Registry
de la Sierra, A., Williams, B., Bursztyn, M., Parati, G., Stergiou, G. S., Vinyoles, E., Segura, J., Gorostidi, M., & Ruilope, L. M. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.22716 · Cited by 19
Self-citationShafi, S., Sarac, E., & Tran, H. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00675.x · Cited by 18
Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension
Burnier, M., & Wuerzner, G. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.003 · Cited by 18
Agarwal, R., & Weir, M. R. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.02.005 · Cited by 18
Percutaneous renal denervation: new treatment option for resistant hypertension and more?
Ewen, S., Ukena, C., Böhm, M., & Mahfoud, F. (2013) · Heart · doi:10.1136/heartjnl-2012-301725 · Cited by 18
Tertiary work-up of apparent treatment-resistant hypertension
Heimark, S., Eskås, P. A., Mariampillai, J. E., Larstorp, A. C. K., Høieggen, A., & Elmula, F. E. M. F. (2016) · Blood Pressure · doi:10.3109/08037051.2016.1172865 · Cited by 18
Future treatments in hypertension: Can we meet the unmet needs of patients?
Kanbay, M., Çöpür, S., Tanrıöver, C., Uçku, D., & Laffin, L. J. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.008 · Cited by 18
Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation
Azzam, O., Nejad, S. H., Carnagarin, R., Nolde, J. M., Kiuchi, M. G., & Schlaich, M. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16247 · Cited by 21
Cifras e impacto de la hipertensión arterial en España
Banegas, J. R., Sánchez-Martínez, M., Gijón‐Conde, T., López‐García, E., Graciani, A., Guallar‐Castillón, P., Puig, J. G., & Rodríguez‐Artalejo, F. (2024) · Revista Española de Cardiología · doi:10.1016/j.recesp.2024.03.002 · Cited by 18
Self-citationEndothelin Antagonism and Hypertension: An Evolving Target
Laffin, L. J., & Bakris, G. L. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.03.001 · Cited by 18
Gordin, D., Elmula, F. E. M. F., Andersson, B., Gottsäter, A., Elf, J. L., Kahan, T., Christensen, K. L., Vikatmaa, P., Vikatmaa, L., Olesen, T. B., et al. (2017) · Blood Pressure · doi:10.1080/08037051.2017.1332477 · Cited by 18
Dopamine β hydroxylase as a potential drug target to combat hypertension
Dey, S. K., Saini, M., Prabhakar, P., & Kundu, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1795830 · Cited by 18
Ambulatory Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension
Islam, M. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_177 · Cited by 18
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension
Ghazi, L., Oparil, S., Calhoun, D. A., Lin, C. P., & Dudenbostel, T. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08632 · Cited by 18
Shuey, M. M., Gandelman, J. S., Chung, C. P., Nian, H., Yu, C., Denny, J. C., & Brown, N. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021640 · Cited by 19
Intermittent fasting ameliorates resistant hypertension through modulation of gut microbiota
Yun, F., Han, X., Wang, Z., Gao, Q., Xu, M., Liu, H., Fang, N., Zhang, Y., Li, Y., & Gong, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107864 · Cited by 18
SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
Patel, H. C., Hayward, C., & Mario, C. D. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.15 · Cited by 18
Principales conclusiones del Consenso Argentino de Hipertensión Arterial
Delucchi, A., Marin, M., Paez, O. B., Bendersky, M., & Rodríguez, P. (2019) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2019.01.001 · Cited by 18
Association between night sleep latency and hypertension: A cross-sectional study
Zhong, X., Gou, F., Jiao, H., Zhao, D., & Teng, J. (2022) · Medicine · doi:10.1097/md.0000000000031250 · Cited by 17
Gijón‐Conde, T., Graciani, A., López‐García, E., Guallar‐Castillón, P., Rodríguez‐Artalejo, F., & Banegas, J. R. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.004 · Cited by 17
Self-citationSolak, Y., Kario, K., Covic, A. C., Bertelsen, N. S., Afşar, B., Özkök, A., Więcek, A., & Kanbay, M. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1184-1 · Cited by 17
Elliott, W. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.02.018 · Cited by 17
Fontes-Guerra, P. C. A., Cardoso, C. R. L., Muxfeldt, E. S., & Salles, G. F. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000589 · Cited by 17
Azizi, M., Perdrix, L., Bobrie, G., Frank, M., Châtellier, G., Ménard, J., & Plouin, P. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000280 · Cited by 17
Metadata
- Authors
- de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M.
- Affiliations
- From the Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona (A.d.l.S.), Hypertension Unit (J.S., L.M.R.), Hospital 12 de Octubre, Madrid, Spain; Department of Preventive Medicine and Public Health (J.R.B., J.J.d.l.C.), Autonomous University, Madrid, Spain; Department of Nephrology (M.G.), Hospital Universitario Central de Asturias, Oviedo, Spain; Department of Internal Medicine (P.A.), Hospital General de L'Hospitalet, Barcelona, Spain; Hypertension Unit (A.O.),...
- Universitat Autònoma de Barcelona (ES)
- Venue
- Hypertension
- Published
- 2011-05
- Volume
- 57
- Issue
- 5
- Pages
- 898-902
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2113750355
- Cited by
- 809
- References
- 32
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 32 · 2023: 33 · 2022: 34 · 2021: 25 · 2020: 35 · 2019: 49 · 2018: 41 · 2017: 48 · 2016: 88 · 2015: 68 · 2014: 115 · 2013: 130 · 2012: 63
- FWCI
- 73.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- resistant hypertension, white coat hypertension, ambulatory blood pressure monitoring, prevalence, cardiovascular risk profile, target organ damage, left ventricular hypertrophy, microalbuminuria, renal dysfunction, cardiovascular disease, duration of hypertension, smoking, diabetes mellitus, antihypertensive therapy
- MeSH terms
- Age Factors, Aged, Antihypertensive Agents, Blood Pressure, Female, Humans, Hypertension, Male, Middle Aged, Registries, Risk, Sex Factors, Smoking, Spain, Prevalence, Chi-Square Distribution, Blood Pressure Monitoring, Ambulatory, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
